Diaphragm rescue alone prevents heart dysfunction in dystrophic mice in vitro

Human Molecular Genetics

Volumn 20, Issue 3, 2011, Pages 413-421

  Crisp, Alastair ^a   Yin, HaiFang ^a,b   Goyenvalle, Aurelie ^a   Betts, Corinne ^a   Moulton, Hong M ^c   Seow, Yiqi ^a   Babbs, Arran ^a   Merritt, Thomas ^a   Saleh, Amer F ^d   Gait, Michael J ^d   Stuckey, Daniel J ^a,e   Clarke, Kieran ^a   Davies, Kay E ^a   Wood, Matthew J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c OREGON STATE UNIVERSITY   (United States)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; OLIGOMER; PEPTIDE CONJUGATED PHOSPHORODIAMIDATE OLIGOMER; UNCLASSIFIED DRUG; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING MUSCLE; CARDIOMYOPATHY; DIAPHRAGM; DUCHENNE MUSCULAR DYSTROPHY; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE; UNIVERSITY; WILD TYPE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CARDIOMYOPATHIES; CYTOSKELETAL PROTEINS; DIAPHRAGM; DYSTROPHIN; HEART; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED MDX; MICE, KNOCKOUT; MICE, TRANSGENIC; MORPHOLINES; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; STROKE VOLUME; UTROPHIN;

ANIMALIA; MUS;

EID: 78651068846     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq477     Document Type: Article

References (41)

1. Muntoni, F., Torelli, S. and Ferlini, A. (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol., 2, 731-740.
2. Love, D.R., Hill, D.F., Dickson, G., Spurr, N.K., Byth, B.C., Marsden, R.F., Walsh, F.S., Edwards, Y.H. and Davies, K.E. (1989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature, 339, 55-58.
3. Tinsley, J.M., Potter, A.C., Phelps, S.R., Fisher, R., Trickett, J.I. and Davies, K.E. (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature, 384, 349-353.
4. Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J.M. and Davies, K. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat. Med., 4, 1441-1444.
5. Squire, S., Raymackers, J.M., Vandebrouck, C., Potter, A., Tinsley, J., Fisher, R., Gillis, J.M. and Davies, K.E. (2002) Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum. Mol. Genet., 11, 3333-3344.
6. Krag, T.O., Bogdanovich, S., Jensen, C.J., Fischer, M.D., Hansen-Schwartz, J., Javazon, E.H., Flake, A.W., Edvinsson, L. and Khurana, T.S. (2004) Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc. Natl Acad. Sci. USA, 101, 13856-13860.
7. Mattei, E., Corbi, N.,DiCerto,M.G., Strimpakos, G., Severini, C.,Onori,A., Desantis, A., Libri, V., Buontempo, S., Floridi, A. et al. (2007) Utrophin up-regulation by an artificial transcription factor in transgenic mice. PLoS One, 2, e774.
8. Wilton, S.D., Lloyd, F., Carville, K., Fletcher, S., Honeyman, K., Agrawal, S. and Kole, R. (1999) Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides. Neuromuscul. Disord., 9, 330-338.
9. Wood, M.J., Gait, M.J. and Yin, H. (2010) RNA-targeted splice-correction therapy for neuromuscular disease. Brain, 133, 957-972.
10. Lu, Q.L., Rabinowitz, A., Chen, Y.C., Yokota, T., Yin, H., Alter, J., Jadoon, A., Bou-Gharios, G. and Partridge, T. (2005) Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc. Natl Acad. Sci. USA, 102, 198-203.
11. Alter, J., Lou, F., Rabinowitz, A., Yin, H., Rosenfeld, J., Wilton, S.D., Partridge, T.A. and Lu, Q.L. (2006) Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat. Med., 12, 175-177.
12. Wu, B., Moulton, H.M., Iversen, P.L., Jiang, J., Li, J., Li, J., Spurney, C.F., Sali, A., Guerron, A.D., Nagaraju, K. et al. (2008) Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc. Natl Acad. Sci. USA, 105, 14814-14819.
13. Yin, H., Moulton, H.M., Seow, Y., Boyd, C., Boutilier, J., Iverson, P. and Wood, M.J. (2008) Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. Hum. Mol. Genet., 17, 3909-3918.
14. Yin, H., Moulton, H.M., Betts, C., Seow, Y., Boutilier, J., Iverson, P.L. and Wood, M.J. (2009) A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice. Hum. Mol. Genet., 18, 4405-4414.
15. Yin, H., Betts, C., Saleh, A.F., Ivanova, G.D., Lee, H., Seow, Y., Kim, D., Gait, M.J. and Wood, M.J. (2010) Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse. Mol. Ther., 18, 819-827.
16. van Deutekom, J.C., Janson, A.A., Ginjaar, I.B., Frankhuizen, W.S., Aartsma-Rus, A., Bremmer-Bout, M., den Dunnen, J.T., Koop, K., van der Kooi, A.J., Goemans, N.M. et al. (2007) Local dystrophin restoration with antisense oligonucleotide PRO051. N. Engl. J. Med., 357, 2677-2686.
17. Kinali, M., Arechavala-Gomeza, V., Feng, L., Cirak, S., Hunt, D., Adkin, C., Guglieri, M., Ashton, E., Abbs, S., Nihoyannopoulos, P. et al. (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol., 8, 918-928.
18. Eagle, M., Bourke, J., Bullock, R., Gibson, M., Mehta, J., Giddings, D., Straub, V. and Bushby, K. (2007) Managing duchenne muscular dystrophy-the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul. Disord., 17, 470-475.
19. Bia,B.L.,Cassidy, P.J.,Young, M.E.,Rafael, J.A., Leighton,B.,Davies,K.E., Radda, G.K. and Clarke, K. (1999) Decreased myocardial nNOS, increased iNOS and abnormalECGs inmousemodels ofDuchennemuscular dystrophy. J. Mol. Cell. Cardiol., 31, 1857-1862.
20. Stedman,H.H., Sweeney,H.L., Shrager, J.B.,Maguire,H.C., Panettieri,R.A., Petrof, B., Narusawa, M., Leferovich, J.M., Sladky, J.T. and Kelly, A.M. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature, 352, 536-539.
21. Quinlan, J.G., Hahn, H.S., Wong, B.L., Lorenz, J.N., Wenisch, A.S. and Levin, L.S. (2004) Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul. Disord., 14, 491-496.
22. Zhang, W., ten Hove, M., Schneider, J.E., Stuckey, D.J., Sebag-Montefiore, L., Bia, B.L., Radda, G.K., Davies, K.E., Neubauer, S. and Clarke, K. (2008) Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. J. Mol. Cell. Cardiol., 45, 754-760.
23. Deconinck, A.E., Rafael, J.A., Skinner, J.A., Brown, S.C., Potter, A.C., Metzinger, L., Watt, D.J., Dickson, J.G., Tinsley, J.M. and Davies, K.E. (1997) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell, 90, 717-727.
24. Jearawiriyapaisarn, N., Moulton, H.M., Buckley, B., Roberts, J., Sazani, P., Fucharoen, S., Iversen, P.L. and Kole, R. (2008) Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol. Ther., 16, 1624-1629.
25. Jearawiriyapaisarn, N., Moulton, H.M., Sazani, P., Kole, R. and Willis, M.S. (2010) Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers. Cardiovasc. Res., 85, 444-453.
26. Hainsey, T.A., Senapati, S., Kuhn, D.E. and Rafael, J.A. (2003) Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Neuromuscul. Disord., 13, 294-302.
27. Goyenvalle, A., Babbs, A., Powell, D., Kole, R., Fletcher, S., Wilton, S.D. and Davies, K.E. (2010) Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping. Mol. Ther., 18, 198-205.
28. Fisher, R., Tinsley, J.M., Phelps, S.R., Squire, S.E., Townsend, E.R., Martin, J.E. and Davies, K.E. (2001) Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Neuromuscul. Disord., 11, 713-721.
29. Deconinck, N., Tinsley, J., De Backer, F., Fisher, R., Kahn, D., Phelps, S., Davies, K. and Gillis, J.M. (1997) Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat. Med., 3, 1216-1221.
30. Wakefield, P.M., Tinsley, J.M., Wood, M.J., Gilbert, R., Karpati, G. and Davies, K.E. (2000) Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther., 7, 201-204.
31. Cerletti, M., Negri, T., Cozzi, F., Colpo, R., Andreetta, F., Croci, D., Davies, K.E., Cornelio, F., Pozza, O., Karpati, G. et al. (2003) Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther., 10, 750-757.
32. Muntoni, F., Cau, M., Ganau, A., Congiu, R., Arvedi, G., Mateddu, A., Marrosu, M.G., Cianchetti, C., Realdi, G. and Cao, A. (1993) Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med., 329, 921-925.
33. Milasin, J., Muntoni, F., Severini, G.M., Bartoloni, L., Vatta, M., Krajinovic, M., Mateddu, A., Angelini, C., Camerini, F., Falaschi, A. et al. (1996) A point mutation in the 5′ splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum. Mol. Genet., 5, 73-79.
34. Townsend, D., Yasuda, S., Li, S., Chamberlain, J.S. and Metzger, J.M. (2008) Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle. Mol. Ther., 16, 832-835.
35. Simmons, D., Linde, L., Miller, J. and O'Reilly, R. (1961) Relation between lung volume and pulmonary vascular resistance. Circ. Res., 9, 465-471.
36. Yotsukura, M., Miyagawa, M., Tsuya, T., Ishihara, T. and Ishikawa, K. (1988) Pulmonary hypertension in progressive muscular dystrophy of the Duchenne type. Jpn Circ. J., 52, 321-326.
37. Ito, K., Kimura, S., Ozasa, S., Matsukura, M., Ikezawa, M., Yoshioka, K., Ueno, H., Suzuki, M., Araki, K., Yamamura, K. et al. (2006) Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Hum. Mol. Genet., 15, 2266-2275.
38. Wu, R.P., Youngblood, D.S., Hassinger, J.N., Lovejoy, C.E., Nelson, M.H., Iversen, P.L. andMoulton, H.M. (2007) Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. Nucleic Acids Res., 35, 5182-5191.
39. Nguyen, T.M., Ellis, J.M., Love, D.R., Davies, K.E., Gatter, K.C., Dickson, G. and Morris, G.E. (1991) Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines, J. Cell Biol., 115, 1695-1700.
40. Schneider, J.E., Cassidy, P.J., Lygate, C., Tyler, D.J., Wiesmann, F., Grieve, S.M., Hulbert, K., Clarke, K. and Neubauer, S. (2003) Fast, high-resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7 T system. J. Magn. Reson. Imaging, 18, 691-701.
41. Ivanova, G.D., Arzumanov, A., Abes, R., Yin, H., Wood, M.J., Lebleu, B. and Gait, M.J. (2008) Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle. Nucleic Acids Res., 36, 6418-6428.